|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 261.70 GBX | +0.11% |
|
+1.30% | +49.24% |
| 1 week | +1.30% | ||
| Current month | +1.79% |
Investment objective
The objective of the LS ARKG Genomic Tracker ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the Reference Asset), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
Off-Hours Price |
Change |
YTD change |
Weight | ||
|---|---|---|---|---|---|
 | 81.80USD | +3.30% | +3.40% | 6.89% | |
| 104.91USD | +0.95% | +3.30% | 6.8% | |
| 60.08USD | +8.02% | +14.57% | 4.53% | |
| 9.200USD | +1.10% | +31.43% | 4.28% | |
| 17.56USD | +1.86% | +95.33% | 4.17% | |
| 29.19USD | -0.21% | +54.94% | 4.15% | |
| 34.79USD | +3.91% | +25.51% | 4.1% | |
| 16.88USD | +2.99% | -5.59% | 3.98% | |
| 2.920USD | -3.31% | +197.17% | 3.95% | |
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | GBX 261.70 | +0.11% | 34 |
| 26-07-02 | GBX 261.40 | -0.42% | 0 |
| 26-07-01 | GBX 262.50 | +2.10% | 0 |
| 26-06-30 | GBX 257.10 | +0.08% | 0 |
| 26-06-29 | GBX 256.90 | -0.56% | 226 |
Other stock markets
End-of-day quote London S.E.
Last update July 02, 2026
Description
| XS2399368062 | |
|---|---|
| Total Expense Ratio | 1.10% |
| Asset Class | Stocks |
| Size | |
| Currency | |
| Provider |
Features and characteristics
| Dividend Policy | Capitalisation |
|---|---|
| Jurisdiction | |
| Fund Structure | |
| Date of creation |
2021-12-13
|
AuM evolution - 2026-02-26
| AuM (GBX) | 52.28M |
|---|---|
| AuM 1M | 54.26M |
| AuM 3 months | 83.38M |
| AuM 6 months | 65.76M |
| AuM 12 months | 50.77M |
- Stock Market
- ETF
- ARKC ETF
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
